# Stoke Therapeutics, Inc. (STOK) FY2026 Q2 Balance Sheet

- Company: Stoke Therapeutics, Inc. (STOK)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-03, accession number 0001193125-26-330557
- Page: https://plicit.ai/financials/stok/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/stok-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 393,966,000 US dollars
- **Current assets**: 322,538,000 US dollars
- **Non-current assets**: 71,428,000 US dollars
- **Liabilities**: 48,419,000 US dollars
- **Current liabilities**: 41,930,000 US dollars
- **Non-current liabilities**: 6,489,000 US dollars
- **Equity**: 345,547,000 US dollars
- **Marketable securities - current**: 182,814,000 US dollars
- **Cash and cash equivalents**: 110,004,000 US dollars
- **Prepaid expenses**: 14,688,000 US dollars
- **Accounts receivable**: 7,179,000 US dollars
- **Other current assets**: 6,313,000 US dollars
- **Interest receivable**: 1,540,000 US dollars
- **Marketable securities - long-term**: 61,502,000 US dollars
- **Property and equipment, net**: 4,829,000 US dollars
- **Restricted cash - long-term**: 3,227,000 US dollars
- **Operating right-of-use assets**: 1,870,000 US dollars
- **Accrued and other current liabilities**: 28,613,000 US dollars
- **Deferred revenue - current portion**: 8,523,000 US dollars
- **Accounts payable**: 4,794,000 US dollars
- **Deferred revenue - net of current portion**: 5,652,000 US dollars
- **Other long-term liabilities**: 837,000 US dollars
- **Additional paid-in capital**: 955,419,000 US dollars
- **Common stock, par value of $0.0001 per share; 300,000,000 shares authorized, 62,402,595 and 58,921,999 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively**: 6,000 US dollars
- **Accumulated deficit**: negative 609,336,000 US dollars
- **Accumulated other comprehensive (loss) income**: negative 542,000 US dollars
- **Gross equity (calculated)**: 955,425,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.